iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models

Human Molecular Genetics

Volumn 25, Issue 15, 2016, Pages 3152-3163

  Nizzardo, Monica ^a   Bucchia, Monica ^a   Ramirez, Agnese ^a   Trombetta, Elena ^b   Bresolin, Nereo ^a   Comi, Giacomo P ^a   Corti, Stefania ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; SIALYL LEWIS X ANTIGEN; VANILLOID RECEPTOR 1; CD15 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; SOD1 G93A PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL PROTECTION; CELL SURVIVAL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MOTONEURON; MUSCLE INNERVATION; NERVE CELL GROWTH; NEURAL STEM CELL; NEUROMUSCULAR JUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TRANSGENIC MOUSE; ALLOGRAFT; ANIMAL; BIOSYNTHESIS; CELL LINE; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; SKELETAL MUSCLE; TRANSPLANTATION;

ALLOGRAFTS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIGENS, CD15; ANTIGENS, CD29; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE, SKELETAL; NEURAL STEM CELLS; RECEPTORS, INTERLEUKIN-8A; STEM CELL TRANSPLANTATION; SUPEROXIDE DISMUTASE;

EID: 85014388202     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw163     Document Type: Article

References (28)

1. Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S.A., Goutman, S.A. and Feldman, E.L. (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat. Rev. Neurol., 11, 266-279.
2. Bucchia, M., Ramirez, A., Parente, V., Simone, C., Nizzardo, M., Magri, F., Dametti, S. and Corti, S. (2015) Therapeutic development in amyotrophic lateral sclerosis. Clin. Ther., 37, 668-680.
3. Renton, A.E., Chio, A. and Traynor, B.J. (2014) State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci., 17, 17-23.
4. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X. et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772-1775.
5. Faravelli, I., Bucchia, M., Rinchetti, P., Nizzardo, M., Simone, C., Frattini, E. and Corti, S. (2014) Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives. Stem Cell Res. Ther., 5, 87.
6. Rizzo, F., Riboldi, G., Salani, S., Nizzardo, M., Simone, C., Corti, S. and Hedlund, E. (2014) Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell. Mol. Life Sci., 71, 999-1015.
7. Moloney, E.B., de Winter, F. and Verhaagen, J. (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci., 8, 252.
8. Corti, S., Locatelli, F., Donadoni, C., Guglieri, M., Papadimitriou, D., Strazzer, S., Del Bo, R. and Comi, G.P. (2004) Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain, 127, 2518-2532.
9. Corti, S., Locatelli, F., Papadimitriou, D., Del Bo, R., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Fortunato, F., Strazzer, S. et al. (2007) Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain, 130, 1289-1305.
10. Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Del Bo, R., Crimi, M., Bordoni, A., Fortunato, F., Strazzer, S., Menozzi, G. et al. (2006) Transplanted ALDHhiSSClo neural stem cells generatemotor neurons and delay disease progression of nmdmice, an animal model of SMARD1. Hum. Mol. Genet., 15, 167-187.
11. Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Del Bo, R., Fortunato, F., Strazzer, S., Salani, S., Bresolin, N. and Comi, G.P. (2005) Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J., 19, 1860-1862.
12. Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Salani, S., Del Bo, R., Strazzer, S., Bresolin, N. and Comi, G.P. (2006) Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells, 24, 975-985.
13. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Saladino, F., Bordoni, A., Fortunato, F., Del Bo, R. et al. (2008) Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J. Clin. Invest., 118, 3316-3330.
14. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Simone, C., Falcone, M., Papadimitriou, D., Locatelli, F. et al. (2010) Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice. Brain, 133, 465-481.
15. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Simone, C., Falcone, M., Riboldi, G., Govoni, A., Bresolin, N. et al. (2010) Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum. Mol. Genet., 19, 3782-3796.
16. Corti, S., Nizzardo, M., Simone, C., Falcone, M., Donadoni, C., Salani, S., Rizzo, F., Nardini, M., Riboldi, G., Magri, F. et al. (2012) Direct reprogramming of human astrocytes into neural stem cells and neurons. Exp. Cell Res., 318, 1528-1541.
17. Nizzardo, M., Simone, C., Rizzo, F., Ruggieri, M., Salani, S., Riboldi, G., Faravelli, I., Zanetta, C., Bresolin, N., Comi, G.P. et al. (2014) Minimally invasive transplantation of iPSCderived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum. Mol. Genet., 23, 342-354.
18. Feldman, E.L., Boulis, N.M., Hur, J., Johe, K., Rutkove, S.B., Federici, T., Polak, M., Bordeau, J., Sakowski, S.A. and Glass, J.D. (2014) Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann. Neurol., 75, 363-373.
19. Tate, M.C., Garcia, A.J., Keselowsky, B.G., Schumm, M.A., Archer, D.R. and LaPlaca, M.C. (2004) Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol. Cell. Neurosci., 27, 22-31.
20. Nagai, M., Re, D.B., Nagata, T., Chalazonitis, A., Jessell, T.M., Wichterle, H. and Przedborski, S. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci., 10, 615-622.
21. Di Giorgio, F.P., Boulting, G.L., Bobrowicz, S. and Eggan, K.C. (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALScausing mutation. Cell Stem Cell, 3, 637-648.
22. Marchetto, M.C., Muotri, A.R., Mu, Y., Smith, A.M., Cezar, G.G. and Gage, F.H. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell, 3, 649-657.
23. Re, D.B., Le Verche, V., Yu, C., Amoroso, M.W., Politi, K.A., Phani, S., Ikiz, B., Hoffmann, L., Koolen, M., Nagata, T. et al. (2014) Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron, 81, 1001-1008.
24. Kariya, S., Re, D.B., Jacquier, A., Nelson, K., Przedborski, S. and Monani, U.R. (2012) Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. Hum. Mol. Genet., 21, 3421-3434.
25. Yang, Y.M., Gupta, S.K., Kim, K.J., Powers, B.E., Cerqueira, A., Wainger, B.J., Ngo, H.D., Rosowski, K.A., Schein, P.A., Ackeifi, C.A. et al. (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell, 12, 713-726.
26. Simone, C., Nizzardo, M., Rizzo, F., Ruggieri, M., Riboldi, G., Salani, S., Bucchia, M., Bresolin, N., Comi, G.P. and Corti, S. (2014) iPSC-Derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1. Stem Cell Rep., 3, 297-311.
27. Perez-Garcia, M.J. and Burden, S.J. (2012) Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep., 2, 497-502.
28. Nizzardo, M., Simone, C., Rizzo, F., Ulzi, G., Ramirez, A., Rizzuti, M., Bordoni, A., Bucchia, M., Gatti, S., Bresolin, N. et al. (2016) Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype. Sci. Rep., 6, 21301.